TY  - GEN
AU  - Alric,L
AU  - Thebault,S
AU  - Peron,J-M
AU  - Balard,P
AU  - Metivier,S
AU  - Pipy,B
AU  - Izopet,J
AU  - Vinel,J-P
TI  - Pilot study of interferon-alpha-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1
SN  - 1352-0504
PY  - 2006///0331
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Drug Therapy, Combination
KW  - Female
KW  - France
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Interleukin-2
KW  - Male
KW  - Middle Aged
KW  - Pilot Projects
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Species Specificity
KW  - Treatment Outcome
KW  - Viral Load
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2893.2005.00694.x
ER  -